Blog - Page 3002 of 5588

MondayJan 07, 2013 2:25 pm

TechPrecision Corp. (TPCS) Signs Exclusive Agreement to Produce Product Assemblies for Proton Beam Radiotherapy Systems

TechPrecision announced that it signed a five-year, $115 million agreement to exclusively produce complete product assemblies for Proton Beam cancer treatment equipment in the U.S. and Asia. This agreement covers production for units that will be used in the U.S. and Asia. TechPrecision is an industry leading manufacturer that provides engineering, precision large-scale machined, fabricated metal, and electrical components for complete tested systems with customers in the alternative energy, cleantech, medical, nuclear, defense, aerospace, and other commercial industries. “This agreement will benefit both our Ranor and WCMC divisions, as we will produce units to meet the market demand in the…

MondayJan 07, 2013 11:05 am

Acquisition Strategy of Bergamo Acquisition Corp. (BGMO)

When Warren Buffett first took control of Berkshire Hathaway, he effectively turned the company around by redirecting its dwindling resources toward the careful purchase of other companies. In much the same mold, Bergamo Acquisition targets a diversified portfolio of companies for sole acquisition or co-investment alongside other investors such as private equity funds, hedge funds, investment banks, and other institutions. Bergamo Acquisition plans to effect management buy-outs, friendly mergers, and value-accretive capital projects. At times the company may provide debt financing as a proprietary investor in the form of bi-laterally negotiated private placements. Bergamo Acquisition has raised investable funds in…

MondayJan 07, 2013 11:05 am

Synthesis Energy Systems, Inc. (SYMX) Begins Producing Methanol at Yima JV Facility in Henan, China

Synthesis Energy Systems, developers of the U-GAS® fluidized bed gasification technology that allows energy producers to fully utilize even the abundant low rank, low cost coal, reported that the Yima Joint Venture project has begun outputting methanol. The company thus moves one major step closer towards meaningful financial traction with the China segment of the business this year, as methanol production at the facility is steadily ramped up to full capacity, with completion of the requisite commissioning and start-up steps being taken care of first. This remarkable cutting-edge facility in Henan Province is the result of a $250M investment in…

MondayJan 07, 2013 7:49 am

International Stem Cell Corp. (ISCO) Proclaims Liver Disease Program’s Success

International Stem Cell Corporation, a company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), today reported positive top line efficacy results from its pre-clinical in vivo liver study. The main goal of this study was to demonstrate the therapeutic equivalence of human parthenogenetic stem cell (hpSC)-derived hepatocytes to adult liver cells as a prerequisite for using such cells in the treatment of metabolic liver diseases, including Crigler-Najjar Syndrome (CNS). CNS is a rare inherited disorder in which bilirubin cannot be broken down by the liver. The build-up of this toxic compound can result in damage to the…

MondayJan 07, 2013 7:49 am

GlobalWise Investments, Inc. (GWIV) Secures New Channel Sales Partnership to Expand Government and Transportation Client Opportunities

Today before the opening bell, GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems, announced the signing of a new channel sales partnership with Iron Data Solutions, Inc. (www.irondata.com). Founded in 2001 to respond to the increasing demand for cost effective business transaction software and services, Iron Data today offers a comprehensive suite of solutions that assess, improve, manage, and monitor challenging operational process issues for clients in the public sectors. Iron Data has more than 400 employees across 11 offices around the…

MondayJan 07, 2013 7:48 am

Talon Therapeutics, Inc. (TLON) Adds Elizabeth Weatherman to Board

Talon Therapeutics, Inc. (TLON) Adds Elizabeth Weatherman to Board Talon Therapeutics recently announced that Elizabeth Weatherman had been appointed to the company’s board of directors. Talon also announced the departure of Jonathan Leff, leaving the Talon board for Deerfield Management. Headquartered in San Francisco, CA, Talon is focused on the development of products intended for the therapy of hematologic malignancies and solid tumors, as well as a product candidate for the treatment-limiting skin toxicities of the EGFR-inhibitor class of cancer therapeutics. Weatherman is a Managing Director of Warburg Pincus (the majority shareholder of Talon), joining in 1988, and leads the…

FridayJan 04, 2013 2:48 pm

Viscount Systems, Inc. (VSYS) Appoints Dennis Raefield as COO

Dennis Raefield, previously President of Honeywell Access Systems and then CEO of Mace Security, recently became the COO of Viscount Systems, a global provider of advanced facility access control systems. Raefield, who has an extensive background in the security industry, has served on the Viscount board. At Honeywell Access Systems, a $100 million division of Honeywell International, Mr. Raefield was responsible for enterprise level access control systems for Fortune 100 clients. He was also the President of Pinkerton Systems Integration, currently Securitas, responsible for access control systems for Fortune 500 clients. Mr. Raefield was also CEO/owner of Omega Corporate Security,…

FridayJan 04, 2013 2:46 pm

Soligenix, Inc. (SNGX) Receives FDA Nod to Initiate Development Program of OrbeShield™

The Food and Drug Administration (FDA) has completed its review and given the go-ahead to Soligenix regarding its Investigational New Drug (IND) application for OrbeShieldTM (oral BDP), which is used to prevent death associated with the gastrointestinal acute radiation syndrome (GI-ARS). GI-ARS occurs after toxic radiation exposure and involves several organ systems, which can result in death within five to 15 days. To-date, there is no established treatment or preventive measure for the GI damage stemming from high-dose radiation exposure, though BDP has been marketed since the early 1970s as the active pharmaceutical ingredient in inhalation products for the treatment…

FridayJan 04, 2013 2:46 pm

Inergetics, Inc. (NRTI) Grabs Some Advertising Muscle Ahead of Big 2013 Brand Push

Inergetics, the nutritional supplement developer for the growing clinical health and sports supplement markets, reported today that the company has appointed award-winning outdoor advertising and marketing firm, AR James Media, Inc., founder, president, and CEO, James DeLucia, to the company’s Board. DeLucia brings an impressive track record to the company, having cut his teeth on the floor of the New York Mercantile Exchange in the late 80′s, before going on to form ALX Energy, Inc., after holding membership in two divisions on the COMEX (1992) and NYMEX (1999). The experience garnered at AR James Media by DeLucia, which specializes in…

FridayJan 04, 2013 8:06 am

Cardium Therapeutics, Inc. (CXM) Scheduled to Present at Biotech Showcase 2013 Investment Conference

Earlier this morning, Cardium Therapeutics announced that its CEO will be presenting at the Biotech Showcase 2013 Conference. This year the annual conference is being held January 7-9 at the Parc 55 Wyndham San Francisco Union Square Hotel. Cardium’s presentation will be available live and by replay. Those unable to attend will be able to access the executive presentation at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar. Cardium will provide a corporate overview as well as a review of its entrepreneurial initiatives, which include strategic partner-enabled product and platform opportunities that have been internally developed based on Cardium’s unique skill set, capabilities, and technology. Current entrepreneurial…

Site Search

Company Search